Public-private partnerships as driving forces in the quest for innovative medicines

BACKGROUND: Despite progress in translational research, we are still falling short in developing the innovative medicines required to address major public health needs. Furthermore, the failure rate, time, and cost required for registration of a new drug are pushing the economics of the industry to...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Michel, Compton, Carolyn, Mittleman, Barbara B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564715/
https://www.ncbi.nlm.nih.gov/pubmed/23369569
http://dx.doi.org/10.1186/2001-1326-2-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564715/
https://www.ncbi.nlm.nih.gov/pubmed/23369569
http://dx.doi.org/10.1186/2001-1326-2-2

Ejemplares similares